FDA Inspection 1198343 — Cipla Limited

Cipla Limited — FEI 3008581988

The FDA completed an inspection of Cipla Limited on February 17, 2023 in Pithampur, District Dhar. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
February 17, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pithampur, District Dhar (India)